What the FDA Has Actually Approved for Weight Management The National Institute of Diabetes and Digestive and Kidney Diseases maintains a plain-language list of prescription medications approved for chronic weight management: orlistat (Xenical, Alli), phentermine-topiramate (Qsymia), naltrexone-bupropion (Contrave), liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound), plus setmelanotide (Imcivree) for specific rare genetic causes of obesity
Rudnicka E, et al
Consider requesting a slower escalation, spending six to eight weeks at each dose level before increasing
Furthermore, smoking can exacerbate RA conditions by increasing the levels of rheumatoid antibodies, inducing coagulation and fibrinolytic disorders, and leading to the formation of rheumatoid nodules and secondary lung lesions [23, 38]
Key variants in the GLP1R gene (like rs6923761) and the FTO gene (rs9939609) influence both your baseline hunger set point and your medication responsiveness